Quick Answer
PHIBRO ANIMAL HEALTH CORP reported Operating Income Loss of $110.47 million for the year ending 2025.
- PHIBRO ANIMAL HEALTH CORP showed an increase of +107.2% in Operating Income Loss from 2024 to 2025.
- This data is from PHIBRO ANIMAL HEALTH CORP's annual report (Form 10-K), filed with the SEC on August 27, 2025.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2012: $13.21 million | Q4 2012: $14.16 million | Q1 2013: $14.46 million | Q2 2013: $14.91 million | Q3 2013: $16.40 million | Q4 2013: $17.02 million | Q1 2014: $17.32 million | Q2 2014: $13.06 million | Q3 2014: $25.11 million | Q4 2014: $19.79 million | Q1 2015: $21.81 million | Q2 2015: $20.96 million | Q3 2015: $21.86 million | Q4 2015: $22.62 million | Q1 2016: $21.17 million | Q3 2016: $21.81 million | Q4 2016: $22.63 million | Q1 2017: $29.97 million | Q3 2017: $22.39 million | Q4 2017: $23.94 million | Q1 2018: $26.49 million | Q3 2018: $22.85 million | Q4 2018: $25.71 million | Q1 2019: $22.57 million | Q3 2019: $10.15 million | Q4 2019: $19.61 million | Q1 2020: $21.32 million | Q3 2020: $15.69 million | Q4 2020: $19.89 million | Q1 2021: $20.13 million | Q3 2021: $14.61 million | Q4 2021: $22.29 million | Q1 2022: $19.19 million | Q3 2022: $13.68 million | Q4 2022: $15.84 million | Q1 2023: $18.55 million | Q3 2023: -$726.0 thousand | Q4 2023: $15.70 million | Q1 2024: $19.92 million | Q3 2024: $17.70 million | Q4 2024: $25.53 million | Q1 2025: $33.52 million | Q3 2025: $51.26 million | Q4 2025: $50.33 million.
- Over the full 14 years of available data (2012 to 2025), PHIBRO ANIMAL HEALTH CORP's Operating Income Loss has grown by 124.0%.
- Historical annual values: Fiscal year 2025: $110.47 million | Fiscal year 2024: $53.32 million | Fiscal year 2023: $71.85 million | Fiscal year 2022: $78.99 million | Fiscal year 2021: $74.87 million | Fiscal year 2020: $69.19 million | Fiscal year 2019: $83.23 million | Fiscal year 2018: $98.93 million | Fiscal year 2017: $97.93 million | Fiscal year 2016: $85.74 million | Fiscal year 2015: $87.67 million | Fiscal year 2014: $63.79 million | Fiscal year 2013: $56.73 million | Fiscal year 2012: $49.33 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: